

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.05242169 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.50061624 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.50061624 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.01609808 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.26016001 |
| 6 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.22256248 |
| 7 | negative regulation of T cell mediated immunity (GO:0002710) | 4.07561650 |
| 8 | detection of other organism (GO:0098543) | 4.00657201 |
| 9 | positive T cell selection (GO:0043368) | 3.91587929 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.87560483 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 3.83670880 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.82875252 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.82790848 |
| 14 | detection of bacterium (GO:0016045) | 3.80829903 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 3.80048124 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 3.77867180 |
| 17 | activated T cell proliferation (GO:0050798) | 3.76889700 |
| 18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.72784899 |
| 19 | T cell selection (GO:0045058) | 3.72457405 |
| 20 | regulation of regulatory T cell differentiation (GO:0045589) | 3.71599941 |
| 21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.66656630 |
| 22 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.62262243 |
| 23 | positive regulation of granulocyte differentiation (GO:0030854) | 3.62054575 |
| 24 | response to type I interferon (GO:0034340) | 3.60535960 |
| 25 | type I interferon signaling pathway (GO:0060337) | 3.58105980 |
| 26 | cellular response to type I interferon (GO:0071357) | 3.58105980 |
| 27 | microglial cell activation (GO:0001774) | 3.56460037 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.50762963 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.49862828 |
| 30 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.48835597 |
| 31 | thymic T cell selection (GO:0045061) | 3.48368148 |
| 32 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.46346720 |
| 33 | interferon-gamma production (GO:0032609) | 3.46142942 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 3.44228894 |
| 35 | leukocyte aggregation (GO:0070486) | 3.43865658 |
| 36 | regulation of tolerance induction (GO:0002643) | 3.42736464 |
| 37 | negative regulation of phagocytosis (GO:0050765) | 3.42196519 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.37162142 |
| 39 | regulation of interferon-alpha production (GO:0032647) | 3.34075093 |
| 40 | response to host immune response (GO:0052572) | 3.29633738 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29633738 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.27821535 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27374300 |
| 44 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26981728 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25991718 |
| 46 | positive regulation of tolerance induction (GO:0002645) | 3.24635173 |
| 47 | B cell mediated immunity (GO:0019724) | 3.24510932 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.24061486 |
| 49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19391016 |
| 50 | leukocyte degranulation (GO:0043299) | 3.19039881 |
| 51 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.19005432 |
| 52 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.19005432 |
| 53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17157339 |
| 54 | T cell migration (GO:0072678) | 3.15922282 |
| 55 | response to interferon-beta (GO:0035456) | 3.14936825 |
| 56 | neutrophil mediated immunity (GO:0002446) | 3.14299812 |
| 57 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.13673851 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.11212438 |
| 59 | cellular response to interferon-beta (GO:0035458) | 3.09457243 |
| 60 | dendritic cell migration (GO:0036336) | 3.07118117 |
| 61 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06929156 |
| 62 | detection of biotic stimulus (GO:0009595) | 3.06164433 |
| 63 | positive regulation of mast cell activation (GO:0033005) | 3.05850499 |
| 64 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.05613927 |
| 65 | response to host (GO:0075136) | 3.05568161 |
| 66 | response to host defenses (GO:0052200) | 3.05568161 |
| 67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05568161 |
| 68 | response to interferon-alpha (GO:0035455) | 3.04397964 |
| 69 | cellular extravasation (GO:0045123) | 3.03726978 |
| 70 | macrophage activation (GO:0042116) | 3.03631659 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 3.03150421 |
| 72 | defense response to protozoan (GO:0042832) | 3.02891436 |
| 73 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.02056320 |
| 74 | dendritic cell chemotaxis (GO:0002407) | 3.01080575 |
| 75 | cellular response to zinc ion (GO:0071294) | 3.00292670 |
| 76 | response to protozoan (GO:0001562) | 2.99690868 |
| 77 | regulation of mast cell activation (GO:0033003) | 2.98375881 |
| 78 | ribosomal small subunit assembly (GO:0000028) | 2.97189699 |
| 79 | negative regulation of adaptive immune response (GO:0002820) | 2.95852378 |
| 80 | T cell receptor signaling pathway (GO:0050852) | 2.95002609 |
| 81 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94250542 |
| 82 | modulation by symbiont of host defense response (GO:0052031) | 2.94250542 |
| 83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94250542 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94250542 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94250542 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 2.94250542 |
| 87 | B cell receptor signaling pathway (GO:0050853) | 2.93837288 |
| 88 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92517392 |
| 89 | mast cell activation (GO:0045576) | 2.92452058 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91962946 |
| 91 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91962946 |
| 92 | negative thymic T cell selection (GO:0045060) | 2.89498011 |
| 93 | actin nucleation (GO:0045010) | 2.89207724 |
| 94 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88674190 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88253473 |
| 96 | myeloid dendritic cell activation (GO:0001773) | 2.86987233 |
| 97 | response to peptidoglycan (GO:0032494) | 2.86583372 |
| 98 | regulation of response to interferon-gamma (GO:0060330) | 2.86261518 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 2.85854707 |
| 100 | negative T cell selection (GO:0043383) | 2.84876742 |
| 101 | respiratory burst (GO:0045730) | 2.83968911 |
| 102 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.78639880 |
| 103 | positive regulation of defense response to virus by host (GO:0002230) | 2.75517284 |
| 104 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.73843854 |
| 105 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72553831 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.71615902 |
| 107 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.71162484 |
| 108 | negative regulation of cell killing (GO:0031342) | 2.71162484 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.71152826 |
| 110 | pinocytosis (GO:0006907) | 2.68954315 |
| 111 | response to interleukin-15 (GO:0070672) | 2.67928115 |
| 112 | positive thymic T cell selection (GO:0045059) | 2.67439045 |
| 113 | neutrophil activation (GO:0042119) | 2.66583275 |
| 114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.61829728 |
| 115 | positive regulation of interferon-beta production (GO:0032728) | 2.61471369 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.58972584 |
| 117 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.58955624 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56533734 |
| 119 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.55767522 |
| 120 | positive regulation of isotype switching (GO:0045830) | 2.55442637 |
| 121 | cellular response to exogenous dsRNA (GO:0071360) | 2.53732110 |
| 122 | regulation of RIG-I signaling pathway (GO:0039535) | 2.52716523 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 2.52695117 |
| 124 | regulation of T cell tolerance induction (GO:0002664) | 2.52549211 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.49273025 |
| 126 | regulation of antigen processing and presentation (GO:0002577) | 2.48159253 |
| 127 | granulocyte activation (GO:0036230) | 2.46187621 |
| 128 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44859245 |
| 129 | doxorubicin metabolic process (GO:0044598) | 2.44133496 |
| 130 | daunorubicin metabolic process (GO:0044597) | 2.44133496 |
| 131 | polyketide metabolic process (GO:0030638) | 2.44133496 |
| 132 | tolerance induction (GO:0002507) | 2.42175215 |
| 133 | cellular response to interleukin-15 (GO:0071350) | 2.39643838 |
| 134 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.39397295 |
| 135 | mature B cell differentiation (GO:0002335) | 2.38061670 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.37736425 |
| 137 | T cell costimulation (GO:0031295) | 2.37715469 |
| 138 | positive regulation of lamellipodium assembly (GO:0010592) | 2.37374570 |
| 139 | natural killer cell mediated immunity (GO:0002228) | 2.37130948 |
| 140 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.37130948 |
| 141 | cellular response to interferon-gamma (GO:0071346) | 2.36182619 |
| 142 | natural killer cell differentiation (GO:0001779) | 2.35564741 |
| 143 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.35405389 |
| 144 | negative regulation of viral genome replication (GO:0045071) | 2.34743708 |
| 145 | lymphocyte costimulation (GO:0031294) | 2.34666544 |
| 146 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.34251049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.00784210 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.99592593 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.16585768 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.95839191 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.93979672 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71454831 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37729662 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.16824167 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12966580 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74143472 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73639150 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65662404 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65191420 |
| 14 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63620213 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54872469 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48059361 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.45815208 |
| 18 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42435874 |
| 19 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39846267 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.22668012 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20477663 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20276051 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.14723528 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02189606 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 1.99422710 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 1.98236938 |
| 27 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94885754 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91577705 |
| 29 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91410868 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91202297 |
| 31 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90823040 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89103436 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.88748577 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84838348 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84075985 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83916904 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83514092 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73945475 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70692432 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70277635 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69845135 |
| 42 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69472437 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65785329 |
| 44 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.65337796 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65307301 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59542001 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.52673917 |
| 48 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52154397 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.51922494 |
| 50 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49309070 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45719018 |
| 52 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45669388 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45478062 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41734874 |
| 55 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.40107960 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39936329 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37734047 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36624385 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35476610 |
| 60 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35118122 |
| 61 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31963461 |
| 62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.31657402 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30038929 |
| 64 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.29489873 |
| 65 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.29396692 |
| 66 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25406095 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24180426 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21876335 |
| 69 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20711909 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19802236 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19333993 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.18904370 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15279508 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11496547 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09479750 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06644082 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04789023 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02191526 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01803727 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01421205 |
| 81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00956886 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00631471 |
| 83 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.99825272 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99729055 |
| 85 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99073757 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98249522 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97694617 |
| 88 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97180209 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96593652 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96541806 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95848132 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95226529 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92689927 |
| 94 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92394447 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92344482 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91159244 |
| 97 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 0.90124707 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89726675 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89328853 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89173326 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89171383 |
| 102 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.88609918 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87368248 |
| 104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87077224 |
| 105 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86151601 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86049697 |
| 107 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86013419 |
| 108 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.84812060 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83570436 |
| 110 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83430490 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82168928 |
| 112 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.82095698 |
| 113 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.81615633 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81194147 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80572520 |
| 116 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.79925397 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78995229 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78330497 |
| 119 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76439572 |
| 120 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76023856 |
| 121 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.75041044 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74008434 |
| 123 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71860336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.02096107 |
| 2 | MP0009785_altered_susceptibility_to | 3.10841872 |
| 3 | MP0005671_abnormal_response_to | 3.09484022 |
| 4 | MP0003436_decreased_susceptibility_to | 2.95515890 |
| 5 | MP0000685_abnormal_immune_system | 2.81894694 |
| 6 | MP0003724_increased_susceptibility_to | 2.69465562 |
| 7 | * MP0001800_abnormal_humoral_immune | 2.64232728 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.62044405 |
| 9 | MP0005025_abnormal_response_to | 2.59655130 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.58125655 |
| 11 | MP0001790_abnormal_immune_system | 2.49526122 |
| 12 | MP0005387_immune_system_phenotype | 2.49526122 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.43797732 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.42918203 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.41491191 |
| 16 | MP0002419_abnormal_innate_immunity | 2.36595073 |
| 17 | * MP0002723_abnormal_immune_serum | 2.35610752 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.29942753 |
| 19 | * MP0001819_abnormal_immune_cell | 2.29464140 |
| 20 | MP0006082_CNS_inflammation | 2.16149348 |
| 21 | * MP0002396_abnormal_hematopoietic_system | 2.13698310 |
| 22 | * MP0002398_abnormal_bone_marrow | 2.06666451 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.06491510 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.06449776 |
| 25 | MP0002006_tumorigenesis | 2.01807054 |
| 26 | MP0003303_peritoneal_inflammation | 1.95578002 |
| 27 | MP0002405_respiratory_system_inflammati | 1.94423584 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.92623718 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.92207812 |
| 30 | * MP0000716_abnormal_immune_system | 1.91938920 |
| 31 | MP0001853_heart_inflammation | 1.79778757 |
| 32 | * MP0000689_abnormal_spleen_morphology | 1.75846696 |
| 33 | MP0001873_stomach_inflammation | 1.74997812 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.72732055 |
| 35 | * MP0002722_abnormal_immune_system | 1.70271068 |
| 36 | MP0004947_skin_inflammation | 1.68002335 |
| 37 | * MP0002429_abnormal_blood_cell | 1.66688385 |
| 38 | MP0004381_abnormal_hair_follicle | 1.66515991 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.66224909 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.66224909 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.64505048 |
| 42 | MP0000490_abnormal_crypts_of | 1.58913926 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.50155851 |
| 44 | MP0000858_altered_metastatic_potential | 1.47862840 |
| 45 | MP0002009_preneoplasia | 1.46297138 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.45246571 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.44483870 |
| 48 | * MP0008469_abnormal_protein_level | 1.44468761 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.42067813 |
| 50 | MP0006054_spinal_hemorrhage | 1.41575413 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.39425573 |
| 52 | MP0003866_abnormal_defecation | 1.37872933 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.33764887 |
| 54 | MP0003448_altered_tumor_morphology | 1.30297945 |
| 55 | MP0000343_altered_response_to | 1.29428433 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.26033687 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.23571380 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.23223385 |
| 59 | MP0008260_abnormal_autophagy | 1.20456260 |
| 60 | MP0004883_abnormal_blood_vessel | 1.20350372 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.16677394 |
| 62 | * MP0009764_decreased_sensitivity_to | 1.14186110 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.12146355 |
| 64 | MP0005451_abnormal_body_composition | 1.12044902 |
| 65 | MP0005310_abnormal_salivary_gland | 1.10093861 |
| 66 | MP0009278_abnormal_bone_marrow | 1.09917188 |
| 67 | MP0002933_joint_inflammation | 1.07936010 |
| 68 | MP0008057_abnormal_DNA_replication | 1.07309055 |
| 69 | MP0005164_abnormal_response_to | 1.04388200 |
| 70 | MP0010307_abnormal_tumor_latency | 1.03403955 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.02919212 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.02188344 |
| 73 | MP0004510_myositis | 1.00008885 |
| 74 | MP0005023_abnormal_wound_healing | 0.98333260 |
| 75 | MP0009763_increased_sensitivity_to | 0.97580994 |
| 76 | MP0003828_pulmonary_edema | 0.96813401 |
| 77 | MP0008007_abnormal_cellular_replicative | 0.96283981 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.93382564 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.92461908 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.89782519 |
| 81 | MP0010368_abnormal_lymphatic_system | 0.89428856 |
| 82 | MP0001851_eye_inflammation | 0.85283304 |
| 83 | MP0009840_abnormal_foam_cell | 0.84822764 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.83698022 |
| 85 | MP0003693_abnormal_embryo_hatching | 0.83587685 |
| 86 | MP0003045_fibrosis | 0.83457080 |
| 87 | MP0003186_abnormal_redox_activity | 0.82442086 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.82391668 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.82083732 |
| 90 | MP0010094_abnormal_chromosome_stability | 0.81911475 |
| 91 | MP0002132_abnormal_respiratory_system | 0.80449217 |
| 92 | MP0003077_abnormal_cell_cycle | 0.79844673 |
| 93 | MP0004130_abnormal_muscle_cell | 0.78397850 |
| 94 | * MP0000249_abnormal_blood_vessel | 0.76978321 |
| 95 | MP0000609_abnormal_liver_physiology | 0.75781250 |
| 96 | MP0005390_skeleton_phenotype | 0.75537761 |
| 97 | MP0000371_diluted_coat_color | 0.71827384 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.71540590 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.71342327 |
| 100 | MP0005166_decreased_susceptibility_to | 0.71143905 |
| 101 | MP0001663_abnormal_digestive_system | 0.69044740 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 0.68205966 |
| 103 | MP0003075_altered_response_to | 0.67927569 |
| 104 | MP0002254_reproductive_system_inflammat | 0.67909793 |
| 105 | MP0005360_urolithiasis | 0.67263532 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.67128272 |
| 107 | * MP0000598_abnormal_liver_morphology | 0.67127056 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.66454186 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.66330201 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.65698642 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.64136160 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.63473808 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.63280378 |
| 114 | MP0003795_abnormal_bone_structure | 0.63266130 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.61682033 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.60737083 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.60678271 |
| 118 | MP0000604_amyloidosis | 0.60071978 |
| 119 | MP0003690_abnormal_glial_cell | 0.52550522 |
| 120 | MP0008873_increased_physiological_sensi | 0.51608316 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.49817741 |
| 122 | MP0003787_abnormal_imprinting | 0.49767063 |
| 123 | MP0004484_altered_response_of | 0.48642397 |
| 124 | MP0009115_abnormal_fat_cell | 0.46515205 |
| 125 | * MP0005319_abnormal_enzyme/_coenzyme | 0.45513402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.88126110 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.75139791 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.50411442 |
| 4 | Myositis (HP:0100614) | 4.42576590 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.25860976 |
| 6 | Recurrent viral infections (HP:0004429) | 3.77025729 |
| 7 | IgM deficiency (HP:0002850) | 3.72909649 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.71785955 |
| 9 | Chronic otitis media (HP:0000389) | 3.68279373 |
| 10 | Keratoconjunctivitis (HP:0001096) | 3.58435940 |
| 11 | Thrombocytosis (HP:0001894) | 3.46997963 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.44046514 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 3.41842293 |
| 14 | Orchitis (HP:0100796) | 3.36740501 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28095319 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.21217260 |
| 17 | T lymphocytopenia (HP:0005403) | 3.17910459 |
| 18 | Pustule (HP:0200039) | 3.17544919 |
| 19 | Recurrent skin infections (HP:0001581) | 3.17170056 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.03343514 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.99425553 |
| 22 | Nasal polyposis (HP:0100582) | 2.98456303 |
| 23 | Periodontitis (HP:0000704) | 2.97870143 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96521628 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96521628 |
| 26 | Vasculitis (HP:0002633) | 2.95476703 |
| 27 | * Abnormality of T cells (HP:0002843) | 2.95415128 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 2.95216329 |
| 29 | Combined immunodeficiency (HP:0005387) | 2.92956989 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.92445528 |
| 31 | Meningitis (HP:0001287) | 2.90717189 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.90048408 |
| 33 | Cellulitis (HP:0100658) | 2.89975297 |
| 34 | Hypochromic anemia (HP:0001931) | 2.85516592 |
| 35 | Petechiae (HP:0000967) | 2.85392097 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.76369059 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.73873445 |
| 38 | Thyroiditis (HP:0100646) | 2.72957472 |
| 39 | * Abnormality of T cell physiology (HP:0011840) | 2.72100305 |
| 40 | Severe combined immunodeficiency (HP:0004430) | 2.71880189 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 2.71647073 |
| 42 | Anorexia (HP:0002039) | 2.69699115 |
| 43 | Eosinophilia (HP:0001880) | 2.68401420 |
| 44 | Leukocytosis (HP:0001974) | 2.67530594 |
| 45 | Optic neuritis (HP:0100653) | 2.66857355 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.66857355 |
| 47 | Pulmonary embolism (HP:0002204) | 2.65059313 |
| 48 | Stomach cancer (HP:0012126) | 2.64118197 |
| 49 | IgG deficiency (HP:0004315) | 2.62123779 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.61394332 |
| 51 | Abnormality of the prostate (HP:0008775) | 2.60919452 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.60513896 |
| 53 | B lymphocytopenia (HP:0010976) | 2.60513896 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60305892 |
| 55 | Obstructive lung disease (HP:0006536) | 2.60305892 |
| 56 | Lymphopenia (HP:0001888) | 2.60031960 |
| 57 | Stomatitis (HP:0010280) | 2.59729113 |
| 58 | Gangrene (HP:0100758) | 2.58685054 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57469165 |
| 60 | Gingivitis (HP:0000230) | 2.56601974 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.56385796 |
| 62 | Granulocytopenia (HP:0001913) | 2.55737395 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.53977845 |
| 64 | Abnormality of eosinophils (HP:0001879) | 2.51158419 |
| 65 | Epistaxis (HP:0000421) | 2.50613932 |
| 66 | Autoimmune hemolytic anemia (HP:0001890) | 2.49357974 |
| 67 | Hematochezia (HP:0002573) | 2.48344688 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.44286373 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.44188398 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.44182356 |
| 71 | Episodic fever (HP:0001954) | 2.43194935 |
| 72 | Gingival bleeding (HP:0000225) | 2.43048516 |
| 73 | IgA deficiency (HP:0002720) | 2.42621616 |
| 74 | Increased IgM level (HP:0003496) | 2.39510239 |
| 75 | Hemoptysis (HP:0002105) | 2.37348497 |
| 76 | Systemic lupus erythematosus (HP:0002725) | 2.36534483 |
| 77 | Osteomyelitis (HP:0002754) | 2.34695052 |
| 78 | Acute hepatic failure (HP:0006554) | 2.34001313 |
| 79 | Colitis (HP:0002583) | 2.32062604 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.31064257 |
| 81 | Abnormal platelet function (HP:0011869) | 2.28881631 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.28881631 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27775052 |
| 84 | Arterial thrombosis (HP:0004420) | 2.27692499 |
| 85 | Encephalitis (HP:0002383) | 2.27239269 |
| 86 | Hypoplasia of the thymus (HP:0000778) | 2.27069870 |
| 87 | Cheilitis (HP:0100825) | 2.25642736 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.24929494 |
| 89 | Joint swelling (HP:0001386) | 2.16236914 |
| 90 | * Chronic diarrhea (HP:0002028) | 2.13825361 |
| 91 | Lymphoma (HP:0002665) | 2.12958968 |
| 92 | Keratitis (HP:0000491) | 2.12396889 |
| 93 | Peritonitis (HP:0002586) | 2.08912115 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 2.08752807 |
| 95 | Papilloma (HP:0012740) | 2.07520352 |
| 96 | Verrucae (HP:0200043) | 2.07520352 |
| 97 | Chest pain (HP:0100749) | 2.07421970 |
| 98 | Skin ulcer (HP:0200042) | 2.07019487 |
| 99 | Glomerulopathy (HP:0100820) | 2.05477081 |
| 100 | Reticulocytopenia (HP:0001896) | 2.05442894 |
| 101 | Abnormality of the fingertips (HP:0001211) | 2.03401638 |
| 102 | Sepsis (HP:0100806) | 2.03245064 |
| 103 | Urticaria (HP:0001025) | 2.03083420 |
| 104 | Abnormal platelet volume (HP:0011876) | 1.97601530 |
| 105 | Prostate neoplasm (HP:0100787) | 1.97409124 |
| 106 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.96650218 |
| 107 | Alveolar cell carcinoma (HP:0006519) | 1.96147681 |
| 108 | Recurrent pneumonia (HP:0006532) | 1.95950871 |
| 109 | Gastrointestinal stroma tumor (HP:0100723) | 1.93721197 |
| 110 | Microcytic anemia (HP:0001935) | 1.93619387 |
| 111 | Skin rash (HP:0000988) | 1.93042392 |
| 112 | Osteolytic defects of the hand bones (HP:0009699) | 1.92928607 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92928607 |
| 114 | Keratoconjunctivitis sicca (HP:0001097) | 1.92327405 |
| 115 | Aplastic anemia (HP:0001915) | 1.91636470 |
| 116 | Abnormality of the endocardium (HP:0004306) | 1.91299581 |
| 117 | Gastrointestinal infarctions (HP:0005244) | 1.91076844 |
| 118 | Increased IgE level (HP:0003212) | 1.90274753 |
| 119 | Vertigo (HP:0002321) | 1.89772299 |
| 120 | Polyneuropathy (HP:0001271) | 1.88559195 |
| 121 | Albinism (HP:0001022) | 1.88328771 |
| 122 | Abnormality of the pleura (HP:0002103) | 1.88021651 |
| 123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.87535203 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.87241367 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.85420500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.85019957 |
| 2 | ERN1 | 2.82802262 |
| 3 | TYK2 | 2.82143163 |
| 4 | TXK | 2.76120889 |
| 5 | MAP3K14 | 2.63472672 |
| 6 | KIT | 2.55407373 |
| 7 | BLK | 2.48234270 |
| 8 | JAK3 | 2.43587981 |
| 9 | TBK1 | 2.40344522 |
| 10 | TGFBR2 | 2.37157092 |
| 11 | IKBKE | 2.30372845 |
| 12 | ZAP70 | 2.21728467 |
| 13 | IRAK4 | 2.18939156 |
| 14 | TEC | 2.15191098 |
| 15 | STK10 | 2.12641922 |
| 16 | KDR | 1.97434473 |
| 17 | CSF1R | 1.87867334 |
| 18 | BTK | 1.81860695 |
| 19 | TNK2 | 1.80493128 |
| 20 | PRPF4B | 1.76764065 |
| 21 | PIM2 | 1.74735515 |
| 22 | JAK1 | 1.72625459 |
| 23 | IRAK3 | 1.65648356 |
| 24 | GRK6 | 1.63848603 |
| 25 | FLT3 | 1.59958374 |
| 26 | ITK | 1.58581590 |
| 27 | NME2 | 1.58549971 |
| 28 | IKBKB | 1.57008072 |
| 29 | FGFR4 | 1.45577643 |
| 30 | TAOK3 | 1.42408943 |
| 31 | MAP2K3 | 1.41868287 |
| 32 | SYK | 1.38479151 |
| 33 | FGFR3 | 1.36729232 |
| 34 | IRAK1 | 1.32968723 |
| 35 | CSK | 1.30126088 |
| 36 | BMPR2 | 1.27129411 |
| 37 | LCK | 1.24832030 |
| 38 | NEK9 | 1.18511226 |
| 39 | FGR | 1.17844800 |
| 40 | RPS6KA4 | 1.17384184 |
| 41 | PIM1 | 1.17053923 |
| 42 | ACVR1B | 1.14093994 |
| 43 | LRRK2 | 1.08381499 |
| 44 | PKN2 | 1.08285082 |
| 45 | CDK12 | 1.08270973 |
| 46 | CHUK | 1.07338500 |
| 47 | CAMKK2 | 1.06040345 |
| 48 | HCK | 1.05532082 |
| 49 | MST4 | 1.03167436 |
| 50 | EEF2K | 1.02181874 |
| 51 | MAP3K10 | 0.98878226 |
| 52 | * LYN | 0.97911122 |
| 53 | TGFBR1 | 0.97355173 |
| 54 | MAP3K13 | 0.96202086 |
| 55 | MATK | 0.94613617 |
| 56 | NLK | 0.94038846 |
| 57 | YES1 | 0.91574586 |
| 58 | TESK2 | 0.87196728 |
| 59 | MAP3K1 | 0.86483140 |
| 60 | EIF2AK3 | 0.84959935 |
| 61 | RIPK4 | 0.84365622 |
| 62 | STK4 | 0.83183348 |
| 63 | SIK2 | 0.83030408 |
| 64 | CLK1 | 0.81744968 |
| 65 | PDK1 | 0.81728098 |
| 66 | EIF2AK1 | 0.81248705 |
| 67 | JAK2 | 0.80304933 |
| 68 | SCYL2 | 0.77121655 |
| 69 | TAOK1 | 0.74532321 |
| 70 | EIF2AK2 | 0.73159327 |
| 71 | PAK4 | 0.70722224 |
| 72 | CDK6 | 0.70692420 |
| 73 | CAMKK1 | 0.69887376 |
| 74 | FES | 0.65794366 |
| 75 | ADRBK2 | 0.65172671 |
| 76 | MAP3K2 | 0.61872392 |
| 77 | IRAK2 | 0.61661031 |
| 78 | MARK2 | 0.61188875 |
| 79 | PIK3CG | 0.60683966 |
| 80 | MAP3K7 | 0.60428651 |
| 81 | TRPM7 | 0.60125751 |
| 82 | MARK3 | 0.60011732 |
| 83 | RIPK1 | 0.59984464 |
| 84 | PASK | 0.59781874 |
| 85 | PTK2B | 0.59175416 |
| 86 | PRKG2 | 0.58819891 |
| 87 | MAP3K6 | 0.56091682 |
| 88 | EPHB1 | 0.55655682 |
| 89 | MAP3K12 | 0.55555098 |
| 90 | MAP3K3 | 0.55119423 |
| 91 | RPS6KB2 | 0.54031385 |
| 92 | MAP3K11 | 0.53262982 |
| 93 | CDK4 | 0.53187447 |
| 94 | MAP3K8 | 0.52908161 |
| 95 | FRK | 0.52557428 |
| 96 | NEK2 | 0.52218365 |
| 97 | MAPK11 | 0.50574558 |
| 98 | FYN | 0.50388148 |
| 99 | CDK7 | 0.49945281 |
| 100 | MAPK7 | 0.49578436 |
| 101 | TIE1 | 0.49007595 |
| 102 | MAPK12 | 0.48580679 |
| 103 | PTK6 | 0.48502757 |
| 104 | EPHA3 | 0.48052589 |
| 105 | CDC7 | 0.47635050 |
| 106 | ATR | 0.47186861 |
| 107 | GRK7 | 0.47133620 |
| 108 | NUAK1 | 0.47099734 |
| 109 | BRSK2 | 0.45602462 |
| 110 | ABL1 | 0.45215955 |
| 111 | PRKCQ | 0.45214609 |
| 112 | MELK | 0.43112683 |
| 113 | MAP2K2 | 0.42712131 |
| 114 | PDPK1 | 0.41492155 |
| 115 | HIPK2 | 0.40971156 |
| 116 | STK38 | 0.40540234 |
| 117 | WNK1 | 0.40418531 |
| 118 | PRKCD | 0.39726207 |
| 119 | MAP2K6 | 0.39023192 |
| 120 | MAPK4 | 0.38388820 |
| 121 | ADRBK1 | 0.38357255 |
| 122 | GRK1 | 0.38109088 |
| 123 | TESK1 | 0.37752808 |
| 124 | MAPKAPK2 | 0.36128320 |
| 125 | SIK3 | 0.36011632 |
| 126 | STK11 | 0.35393297 |
| 127 | STK16 | 0.34848207 |
| 128 | RPS6KA6 | 0.34027927 |
| 129 | TLK1 | 0.33243357 |
| 130 | TRIB3 | 0.31767269 |
| 131 | IGF1R | 0.31737159 |
| 132 | AURKB | 0.31658764 |
| 133 | MAP3K5 | 0.30987776 |
| 134 | PRKD2 | 0.30519776 |
| 135 | RET | 0.30236195 |
| 136 | KSR2 | 0.30095822 |
| 137 | SGK2 | 0.29786692 |
| 138 | OXSR1 | 0.29719543 |
| 139 | SGK3 | 0.27895517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.27057352 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66150753 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51012865 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46774223 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.33201325 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28195883 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.27896574 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10149681 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.00795828 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00786988 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.97963205 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96166832 |
| 13 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92368277 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91838470 |
| 15 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85032044 |
| 16 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.81278138 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79831818 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74279553 |
| 19 | * Legionellosis_Homo sapiens_hsa05134 | 1.62322592 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61389655 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60567308 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.56854627 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.55441347 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.54224792 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53257689 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50752280 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 1.48817312 |
| 28 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.43996135 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34280995 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33657060 |
| 31 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33081326 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.27723296 |
| 33 | * Apoptosis_Homo sapiens_hsa04210 | 1.26268548 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.25648792 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23041320 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.21106540 |
| 37 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18242926 |
| 38 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.17917379 |
| 39 | * Tuberculosis_Homo sapiens_hsa05152 | 1.15958097 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13583616 |
| 41 | * Hepatitis B_Homo sapiens_hsa05161 | 1.11601198 |
| 42 | Mismatch repair_Homo sapiens_hsa03430 | 1.11048938 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10871586 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09663781 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05564773 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04738471 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.01332083 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00362204 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00006906 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99324608 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98364316 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96503601 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.94110452 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92495014 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89580930 |
| 56 | * Viral myocarditis_Homo sapiens_hsa05416 | 0.89568352 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85629178 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.85412128 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83295894 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.81754211 |
| 61 | * p53 signaling pathway_Homo sapiens_hsa04115 | 0.81608059 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80004573 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79431961 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.78444176 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77585552 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76428953 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76268386 |
| 68 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73673476 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72670144 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71809487 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70641352 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70168150 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69585708 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69070966 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68825294 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68583471 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68350952 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66541150 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65784032 |
| 80 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65480663 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64867594 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64358204 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60811427 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.58646647 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58628334 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55891708 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55650455 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55166341 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54790484 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54546412 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54357680 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52597217 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51345935 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50703897 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49609899 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.49413497 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49104986 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48680027 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48547062 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48322172 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48021254 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47663542 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47658471 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46929671 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46838036 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46647584 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.46214520 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.45801505 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45588811 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44184260 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43465669 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42877025 |
| 113 | Spliceosome_Homo sapiens_hsa03040 | 0.42748782 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42390983 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41260637 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40858509 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40760541 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39734150 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.37956083 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37067112 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36665211 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36007372 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35719429 |
| 124 | Proteasome_Homo sapiens_hsa03050 | 0.35615767 |
| 125 | RNA degradation_Homo sapiens_hsa03018 | 0.34803028 |
| 126 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34604682 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34365770 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33137998 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28951237 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27575794 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26893189 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23880908 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22271555 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21351370 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20082003 |

